Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce M Hoek

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Peerj|June 18, 2020
The effect of journal guidelines on the reporting of antibody validationJoyce M Hoek, Wytske M Hepkema, Willem Halffman
International Journal of Cancer|November 22, 2021
Misidentified biomedical resources: Journal guidelines are not a quick fixWytske M Hepkema, Serge P J M Horbach, Joyce M Hoek, et al.
Drug Discovery Today|January 8, 2026
Gaining regulatory acceptance for novel technologies in nonclinical drug development: A scoping review of its conceptualization in scientific literatureIvar T van der Zee, Joyce M Hoek, Jarno Hoekman, et al.
Frontiers in Medicine|August 1, 2024
Assessing the credibility of a drug's effects: identification and judgment of uncertainty by the Dutch Medicines Evaluation BoardJoyce M Hoek, Jonna Brenninkmeijer, Ymkje Anna de Vries, et al.
British Journal of Clinical Pharmacology|May 14, 2026
Decoding RNA regulation: Challenges and opportunities for RNA-based therapies in EuropeOlivia C Lewis, Christine Leopold, Joyce M Hoek, et al.
Plos One|July 23, 2021
Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findingsJoyce M Hoek, Sarahanne M Field, Ymkje Anna de Vries, et al.
Drug Discovery Today|April 5, 2026
Shaping national networks to improve patient access to advanced therapy medicinal products in EuropeJoyce M Hoek, Mike Broeders, Juan Francisco Hernandez, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Peerj|June 18, 2020
The effect of journal guidelines on the reporting of antibody validationJoyce M Hoek, Wytske M Hepkema, Willem Halffman
International Journal of Cancer|November 22, 2021
Misidentified biomedical resources: Journal guidelines are not a quick fixWytske M Hepkema, Serge P J M Horbach, Joyce M Hoek, et al.
Drug Discovery Today|January 8, 2026
Gaining regulatory acceptance for novel technologies in nonclinical drug development: A scoping review of its conceptualization in scientific literatureIvar T van der Zee, Joyce M Hoek, Jarno Hoekman, et al.
Frontiers in Medicine|August 1, 2024
Assessing the credibility of a drug's effects: identification and judgment of uncertainty by the Dutch Medicines Evaluation BoardJoyce M Hoek, Jonna Brenninkmeijer, Ymkje Anna de Vries, et al.
British Journal of Clinical Pharmacology|May 14, 2026
Decoding RNA regulation: Challenges and opportunities for RNA-based therapies in EuropeOlivia C Lewis, Christine Leopold, Joyce M Hoek, et al.
Plos One|July 23, 2021
Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findingsJoyce M Hoek, Sarahanne M Field, Ymkje Anna de Vries, et al.
Drug Discovery Today|April 5, 2026
Shaping national networks to improve patient access to advanced therapy medicinal products in EuropeJoyce M Hoek, Mike Broeders, Juan Francisco Hernandez, et al.
Pageof 1